AFT Pharmaceuticals Limited (AFT.NZ)
AFT Pharmaceuticals Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Auckland, AU, NZ. The stock last traded at $4.47, down 1.11% on the session, giving a market capitalisation of $468.8M. Its beta of 0.47 implies it has historically moved less than the broad market.
AFT Pharmaceuticals, along with its subsidiaries, focuses on the creation and distribution of pharmaceutical products across New Zealand, Australia, Asia, and other global markets. Their extensive product range addresses a variety of health categories, including but not limited to allergy relief, cold and flu remedies, digestive health, eye care, first aid essentials, nail and oral care, pain management, skincare solutions, and nutritional supplements. This company was established in 1997 and its main office is located in Auckland, New Zealand.
AFT Pharmaceuticals Limited is most often compared with the following Healthcare names: